ALKS-33

Known as: RDC-0313 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2015
0120102015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Major depressive disorder (MDD) is a common psychiatric disease worldwide. The clinical use of tricyclic antidepressants (TCAs… (More)
Is this relevant?
Review
2015
Review
2015
Psychopharmacologic treatment is playing a greater role in the management of patients with eating disorders. In this paper, we… (More)
  • table 1
Is this relevant?
2013
2013
OBJECTIVE To assess preliminarily the effectiveness of a novel opioid antagonist, ALKS-33, in binge eating disorder (BED… (More)
  • table 1
  • figure 1
  • table 3
  • table 2
Is this relevant?
Review
2011
Review
2011
INTRODUCTION Studies have shown that opioid antagonists like naltrexone are efficient in reducing heavy drinking. The… (More)
Is this relevant?
2010
2010
The 240th National Meeting of the American Chemical Society, held in Boston, included topics covering new therapeutic research… (More)
Is this relevant?